Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 21504252)

1.

Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.

Frei CR, Labreche MJ, Attridge RT.

Drugs. 2011 Apr 16;71(6):757-70. doi: 10.2165/11585430-000000000-00000.

PMID:
21504252
2.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
3.

Diagnosis and management of community-acquired pneumonia in adults.

Watkins RR, Lemonovich TL.

Am Fam Physician. 2011 Jun 1;83(11):1299-306.

4.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

PMID:
16801748
5.
6.
7.

Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.

Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM.

Crit Care Med. 2012 Aug;40(8):2310-4. doi: 10.1097/CCM.0b013e31825151a8.

8.
9.

Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.

Yoon YK, Kim EJ, Chun BC, Eom JS, Park DW, Sohn JW, Kim MJ.

Respirology. 2012 Jan;17(1):172-9. doi: 10.1111/j.1440-1843.2011.02077.x.

PMID:
21995414
10.

Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.

Segreti J, House HR, Siegel RE.

Am J Med. 2005 Jul;118 Suppl 7A:21S-28S. Review.

PMID:
15993674
11.

Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward?

Ruhe J, Mildvan D.

Infect Dis Clin North Am. 2013 Mar;27(1):115-32. doi: 10.1016/j.idc.2012.11.004. Epub 2012 Dec 1. Review.

PMID:
23398869
12.

Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Thiem U, Heppner HJ, Pientka L.

Drugs Aging. 2011 Jul 1;28(7):519-37. doi: 10.2165/11591980-000000000-00000. Review.

PMID:
21721597
13.
14.

Antibiotic treatment strategies for community-acquired pneumonia in adults.

Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ; CAP-START Study Group.

N Engl J Med. 2015 Apr 2;372(14):1312-23. doi: 10.1056/NEJMoa1406330.

PMID:
25830421
15.

Fluoroquinolones in the management of community-acquired pneumonia in primary care.

Wispelwey B, Schafer KR.

Expert Rev Anti Infect Ther. 2010 Nov;8(11):1259-71. doi: 10.1586/eri.10.110. Review.

PMID:
21073291
16.
17.

How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.

Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman IM.

J Antimicrob Chemother. 2003 Oct;52(4):555-63. Epub 2003 Sep 12. Review.

18.

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Yoo BK, Triller DM, Yong CS, Lodise TP.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. Epub 2004 Jun 8. Review.

PMID:
15187209
19.

Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.

Ambroggio L, Taylor JA, Tabb LP, Newschaffer CJ, Evans AA, Shah SS.

J Pediatr. 2012 Dec;161(6):1097-103. doi: 10.1016/j.jpeds.2012.06.067. Epub 2012 Aug 15.

PMID:
22901738
20.

Community-acquired pneumonia: the U.S. perspective.

Niederman MS.

Semin Respir Crit Care Med. 2009 Apr;30(2):179-88. doi: 10.1055/s-0029-1202937. Epub 2009 Mar 18. Review.

PMID:
19296418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk